Human O6-methylguanine-DNA methyltransferase containing C145A does not prevent hepatocellular carcinoma in C3HeB/FeJ transgenic mice

Maryanne C.S. Herzig, Kim Hildreth, Jessica Huamani, Marissa Perez, Beth A. Goins, C. Alex Mcmahan, Robert L. Reddick, Christi A. Walter

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The prevalence of hepatocellular carcinoma (HCC) was diminished from 60% to 18% at 15 months of age in C3HeB/FeJ male transgenic mice expressing hMGMT in our previous studies. To directly test if the methyltransferase activity is required for diminished tumor prevalence, two separate lines of transgenic mice bearing an enzymatically inactive form of hMGMT were used. In these lines, cysteine 145 was substituted with alanine (C145A). Expression of the hMGMT C145A transgene in liver was demonstrated by Northern blots and Western blots. Immunohistochemistry revealed predominantly nuclear localization of the hMGMT C145A protein. hMGMT C145A transgenic mice were crossed with lacI transgenic mice to assess mutant frequencies in the presence of the mutant protein. Mutant frequencies were similar among livers of lacI×hMGMT C145A bi-transgenic mice and lacI×wild-type (WT) mice. DNA sequence analysis of recovered lacI mutants revealed similar mutation spectra for hMGMT C145A and WT mice. The prevalence of HCC was also similar for the two tested lines of hMGMT C145A mice, 45% and 48% prevalence with median tumor sizes of 11 and 8mm, and WT mice, 40% prevalence and median tumor size of 10mm. These results provide evidence that residue C145 in hMGMT is required to reduce the prevalence of HCC in C3HeB/FeJ mice transgenic for hMGMT.

Original languageEnglish (US)
Pages (from-to)275-285
Number of pages11
JournalMolecular Carcinogenesis
Issue number4
StatePublished - Apr 1 2013


  • Computed tomography
  • DNA repair
  • Imaging
  • Liver cancer
  • Mouse model

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research


Dive into the research topics of 'Human O<sup>6</sup>-methylguanine-DNA methyltransferase containing C145A does not prevent hepatocellular carcinoma in C3HeB/FeJ transgenic mice'. Together they form a unique fingerprint.

Cite this